Sana Biotechnology: Mayo Clinic Deal A Positive Step On A Long Journey [Seeking Alpha]
Sana Biotechnology, Inc. (SANA)
Company Research
Source: Seeking Alpha
The partnership will leverage Mayo Clinic's clinical, operational, and surgical expertise to optimize SC451's development, delivery, and adoption. Mayo Clinic is making an equity investment in SANA, with an option for further investment, signaling strong institutional confidence. SANA's focus is now solely on SC451, aiming for a single-administration, hypoimmune cell therapy to eliminate insulin dependence and immunosuppression in T1D. Looking for more investing ideas like this one? Get them exclusively at Haggerston BioHealth. Learn More » zorazhuang/E+ via Getty Images Investment Overview The stock of Sana Biotechnology, Inc. ( SANA ) is up nearly 10% in trading, valued at ~$3.5 (at the time of writing), with a market cap valuation of $934m. The catalyst for gains is news shared today by the Seattle More on my IG service If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the ke
Show less
Read more
Impact Snapshot
Event Time:
SANA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SANA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SANA alerts
High impacting Sana Biotechnology, Inc. news events
Weekly update
A roundup of the hottest topics
SANA
News
- Sana Biotechnology (SANA) had its "outperform" rating reaffirmed by Wedbush.MarketBeat
- Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451GlobeNewswire
- Sana Biotechnology, Inc. (SANA) Presents at The Citizens Life Sciences Conference 2026 Transcript [Seeking Alpha]Seeking Alpha
- Sana Biotechnology (SANA) had its "overweight" rating reaffirmed by Morgan Stanley.MarketBeat
- Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression [Yahoo! Finance]Yahoo! Finance
SANA
Earnings
- 8/11/25 - Beat
SANA
Sec Filings
- 4/13/26 - Form 424B5
- 4/13/26 - Form 8-K
- 4/8/26 - Form 4
- SANA's page on the SEC website